Peyronies Society Forums

Peyronies Disease TREATMENT Discussion Boards => Developmental Drugs & Treatments => Topic started by: hope794 on June 09, 2018, 07:48:50 PM

Title: Can this new Phase2 treatment be useful for Peyronies Disease?
Post by: hope794 on June 09, 2018, 07:48:50 PM
Hi all. I was doing some research about new treatments for our disease, and i was looking at clinical trials of a similiar kind of fibrosis: the IPF. I found this:

https://pulmonaryfibrosis-org.clinicaltrialconnect.com/trials/NCT03538301

Do you think that this may be useful for Peyronies Disease too in the future? I'm asking here because it looks promising, but i am not english mothertongue and i dont understand super well every technical word. So please excuse me for asking here.
Title: Re: Can this new Phase2 treatment be useful for Peyronies Disease?
Post by: Freemason on June 10, 2018, 03:27:05 PM
Well..this study is looking at a compound and its effects on those with IPF.  Here's the thing..just bc someone finds a compound that works to reduce fibrosis in the lung doesnt mean it will work in the penis. Sometimes these compounds are specifically tailored to lung tissue..lung cells are entirely diff then penis cells...etc.

Now maybe this compound isnt specific to lung tissue idk.
Title: Re: Can this new Phase2 treatment be useful for Peyronies Disease?
Post by: hope794 on June 10, 2018, 06:11:43 PM
Freemason, thank you very much for your reply.

That's exactly what i wanted to know: there are many studies that claim to solve 'fibrotic issues' but often they don't specify if their studies aim to solve EVERY fibrotic issue or just, for example, IPF or kidney fibrosis and so on.

If someone mothertongue wants to read the article, maybe he may explain to us. I couldn't understand the article properly, unfortunately..